| Characteristic | |
|---|---|
| Mean age, years (n = 328) | 38.1 |
| Age, years (n = 328) | |
| 18–24 | 2.1 |
| 25–34 | 23.2 |
| 35–44 | 74.7 |
| Race/ethnicity (n = 229) | |
| White | 69.4 |
| Black | 17.5 |
| Asian | 3.1 |
| Hispanic | 7.4 |
| American Indian/Alaska Native | 1.3 |
| Other | 1.8 |
| Insurance (n = 300) | |
| Medicare | 10.0 |
| Medicaid | 43.0 |
| Private | 32.3 |
| None | 7.0 |
| Other | 7.7 |
| Marital status (n = 291) | |
| Married/partnered | 49.1 |
| Divorced/separated | 14.1 |
| Single | 36.8 |
| Evidence that patient is non-English speaking (n = 304) | 4.9 |
| Conditions (n = 328) | |
| Hypertension | 63.4 |
| Hypercholesterolemia | 56.7 |
| Diabetes | 56.7 |
| 1 condition | 45.1 |
| 2 conditions | 32.9 |
| 3 conditions | 22.0 |
| Medications (n = 328) | |
| Statin | 54.9 |
| ACE-I | 64.3 |
| ARB | 6.4 |
| 1 medication | 74.7 |
| 2 medications | 25.0 |
| 3 medications | 0.3 |
| Median number of visits during the last year (n = 185) | 4 |
| Median number of providers seen during the past year (n = 186) | 2 |
Data provided as percentages unless otherwise indicated.
ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.